<DOC>
	<DOCNO>NCT00443222</DOCNO>
	<brief_summary>This 4 month open trial TNF-blockade use infliximab ( antibody block TNF ) adult patient chronic myositis ( polymyositis , dermatomyositis , inclusion body myositis ) persist muscle weakness inflammatory active disease despite adequate treatment immunosuppressive either currently previously . Infliximab give infusion , 5 mg/kg body weight , infusion repeat 2 , 6 14 week . The study involve 15 adult patient . Primary outcome measure muscle function assess muscle function index score . Other outcome measure Myositis Disease Activity core set : Patient ’ global assessment physician global assessment visual analogue scale ( VAS ) . Manual muscle test , Health assessment questionnaire ( HAQ ) , serum level CPK , LD extra muscular disease activity score . Muscle biopsy , Magnetic resonance imaging ( MRI ) thigh muscle Health relate Quality life , measure SF-36 .</brief_summary>
	<brief_title>Treatment With TNF Blockade , Infliximab , Patients With Myositis</brief_title>
	<detailed_description />
	<mesh_term>Myositis</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Adult patient . Persisting muscle weakness define ≤ 80 % muscle strength measure functional index myositis Signs disease activity define muscle edema observe magnetic resonance imaging ( MRI ) creatine kinase ( CK ) elevation , inflammatory cell infiltrate muscle biopsy , failure respond treatment glucocorticoid minimum six month combination azathioprine methotrexate . Pregnant woman , nurse mother plan pregnancy within one half year enrolment . Prior administration infliximab therapeutic agent target reduce TNF ( e.g. , Etanercept , pentoxifylline , thalidomide antiCD4+ antibody ) within previous six month . A history know allergy murine protein . Serious infection , hepatitis , pneumonia , pyelonephritis previous 3 month . Less serious infection previous 3 month , acute upper respiratory tract infection ( cold ) uncomplicated urinary tract infection ( cold ) uncomplicated urinary tract infection need consider exclusion discretion treat physician . History opportunistic infection herpes zoster within 2 month screen . Evidence active CMV , active pneumocystis carinii , drug resistant atypical mycobacterium , etc . Documented HIV infection . Current sign symptom severe , progressive uncontrolled renal , hepatic , hematologic , endocrine , pulmonary , cardiac , neurologic cerebral disease . Any currently know malignancy premalignant lesion history malignancy within past five year . Patients alcoholism , alcoholic liver disease , chronic liver disease . Patients positive PPD chest XRay suggestive active TB previous exposure TB .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>infliximab</keyword>
	<keyword>polymyositis</keyword>
	<keyword>dermatomyositis</keyword>
	<keyword>inclusion body myositis</keyword>
</DOC>